Literature DB >> 23960847

Synthesis and anticancer activity of some fused pyrimidines and related heterocycles.

S A Al-Issa1.   

Abstract

On account of the reported anticancer of pyrimidine and condensed pyrimidine, a new pyrimido [3,2-b]-1,2,4,5-tetrazine 3a , b , 5c , d , 6, 9, pyrimido [3,2-b]-1,2,4-triazine 10, 11, pyrimido [3,2-b]-1,2,4-triazole 12 and pyrimidine derivatives 1,2a , b , 4c , d , 8, 13, 14, 15 and 16 were synthesized through different chemical reactions. Structures of all synthesized compounds were supported by spectral and elemental analyses. The obtained compounds were evaluated for their in vitro antitumor activity against human liver cancer cell line (HEPG2).

Entities:  

Keywords:  Anticancer; Pyrimidine derivatives; Pyrimido[3,2-b]-1,2,4,5-tetrazine; Pyrimido[3,2-b]-1,2,4-triazole; Pyrimido[3,2-b]1,2,4-triazine

Year:  2012        PMID: 23960847      PMCID: PMC3745201          DOI: 10.1016/j.jsps.2012.09.002

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  21 in total

1.  Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity.

Authors:  G L Bundy; D E Ayer; L S Banitt; K L Belonga; S A Mizsak; J R Palmer; J M Tustin; J E Chin; E D Hall; K L Linseman
Journal:  J Med Chem       Date:  1995-10-13       Impact factor: 7.446

2.  Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.

Authors:  T E Renau; C Kennedy; R G Ptak; J M Breitenbach; J C Drach; L B Townsend
Journal:  J Med Chem       Date:  1996-08-30       Impact factor: 7.446

Review 3.  Targeting RSK: an overview of small molecule inhibitors.

Authors:  Tam Luong Nguyen
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

4.  Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties.

Authors:  Martin J Di Grandi; Kevin J Curran; Ellen Z Baum; Geraldine Bebernitz; George A Ellestad; Wei-Dong Ding; Stanley A Lang; Miriam Rossi; Jonathan D Bloom
Journal:  Bioorg Med Chem Lett       Date:  2003-10-20       Impact factor: 2.823

5.  Therapeutic potential of new Pt(II) and Ru(III) triazole-pyrimidine complexes against Leishmania donovani.

Authors:  Rosa Magán; Clotilde Marín; María Jose Rosales; Juan Manuel Salas; Manuel Sánchez-Moreno
Journal:  Pharmacology       Date:  2004-09-27       Impact factor: 2.547

6.  Ring opening of nucleoside 1',2'-epoxides with organoaluminum reagents: stereoselective entry to ribonucleosides branched at the anomeric position.

Authors:  Kazuhiro Haraguchi; Yutaka Kubota; Hiromichi Tanaka
Journal:  J Org Chem       Date:  2004-03-19       Impact factor: 4.354

7.  QSAR studies on carbonic anhydrase inhibitors: a case of ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides.

Authors:  Vijay K Agrawal; Ruchi Sharma; Padmakar V Khadikar
Journal:  Bioorg Med Chem       Date:  2002-09       Impact factor: 3.641

8.  Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim.

Authors:  L F Kuyper; J M Garvey; D P Baccanari; J N Champness; D K Stammers; C R Beddell
Journal:  Bioorg Med Chem       Date:  1996-04       Impact factor: 3.641

9.  Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities.

Authors:  Dalal A Abou El Ella; Mostafa M Ghorab; Eman Noaman; Helmy I Heiba; Amira I Khalil
Journal:  Bioorg Med Chem       Date:  2007-11-29       Impact factor: 3.641

10.  Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.

Authors:  K S Atwal; B N Swanson; S E Unger; D M Floyd; S Moreland; A Hedberg; B C O'Reilly
Journal:  J Med Chem       Date:  1991-02       Impact factor: 7.446

View more
  3 in total

1.  Synthesis, characterization and anti-breast cancer activity of new 4-aminoantipyrine-based heterocycles.

Authors:  Mostafa M Ghorab; Marwa G El-Gazzar; Mansour S Alsaid
Journal:  Int J Mol Sci       Date:  2014-05-02       Impact factor: 5.923

2.  Multicomponent synthesis of dispiroheterocycles using a magnetically separable and reusable heterogeneous catalyst.

Authors:  Yogesh Kumar Tailor; Sarita Khandelwal; Kanchan Verma; Ram Gopal; Mahendra Kumar
Journal:  RSC Adv       Date:  2020-10-06       Impact factor: 4.036

Review 3.  Therapeutic potential of heterocyclic pyrimidine scaffolds.

Authors:  Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-04-04       Impact factor: 4.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.